Eleanor Health, a startup applying harm reduction to addiction and other mental health issues, raised $50 million in Series C funding led by General Catalyst, CEO Corbin Petro tells Axios exclusively.
Why it matters: Rates of addiction and overdose have risen sharply amid the pandemic. Rather than requiring people to abstain entirely from drugs and alcohol — a strict approach that's seen mixed results — Eleanor provides wraparound treatment including therapy, peer coaching, case management and medications, including medication assisted treatment (MAT).
